MANNKIND GETS F.D.A. OK

June 28, 2014 1:41 AM

7 0

MANNKIND GETS F.D.A. OK

MannKind Corp. announced Friday afternoon that it has received long-sought-after FDA approval for its candidate diabetes treatment, Afrezza.

The third time was the charm for the Valencia-based company and its revolutionary insulin powder. Delivered with a whistle-sized inhaler, it acts more rapidly than Eli Lilly’s or Novo Nordisk’s injectable insulins and could reduce or eliminate the need for needles completely, depending on the patien...

Also read: David Cassidy, dementia and his tragic family history

Read more

To category page

Loading...